Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Compares two bowel reconnection surgeries in people with Crohn disease

Compares two ways of reconnecting the bowel after resection in Crohn disease.

Plain-language title generated from the registry record
Registry title: Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Key facts

Where
Nanjing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 60 years old?

Source: NCT05658081, who can take part

Where in China

  • Department of General Surgery, Jinling hosptal,Medical School of Nanjing UniversityNanjing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Jinling Hospital, China
Trial code
NCT05658081
Record updated
20 December 2022
Original description
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.Read full original descriptionShow less

Stapled Antimesenteric Functional End-to-end Anastomosis (Kono-S) Versus Stapled Antimesenteric Isoperistaltic Side-to-side Anastomosis for the Postoperative Recurrence of Crohn's Disease: a Randomized Control Trial Study

The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.

Inclusion: patients with Crohn's disease needing bowel resection and anastomosis; ileocolic anastomosis;; written consent acquired.

Exclusion: patients underwent enterostomy; small bowel anastomosis; anticipating other trial.

ClinicalTrials.gov NCT05658081